In 2012, Seneca Nation Businessman J.C. Seneca formed the JC Seneca Foundation (JCSF) with a mission to form partnerships that promote the physical, emotional, intellectual and spiritual well-being of Native people and their surrounding communities. Since then, Seneca has realized that mission by supporting charitable programs such as It Takes a Tribe, providing sponsorships for initiatives including Bikers Against Child Abuse and The Ride for Dialysis, and forming partnerships with community health organizations such as G-Health Enterprises and Harmonia Collaborative Care. As JCSF moves into its second decade, Seneca is taking steps to further his foundation’s impact.

Today, the Ride for Roswell, presented by the West Herr Automotive Group, launched registration for the 2022 event, which will take place on Saturday, June 25 at the University at Buffalo. Online registration is available at www.rideforroswell.org. 

Metastasis, or spread of a cancer tumor from one organ to another, is a complex process about which much is still unknown. A collaborative research team led by scientists from Roswell Park Comprehensive Cancer Center and Wake Forest University Baptist Medical Center has determined that a small protein, RAC1, actively recruits enzymes involved in nucleotide production to promote cancer metastasis. Their findings, published in Nature Communications, suggest that targeting this interaction may provide a new strategy for treating advanced cancers.

A study led by scientists at Roswell Park Comprehensive Cancer Center shows that chemotherapy after surgery for gastric adenocarcinoma is significantly associated with longer survival in patients with chemosensitive disease, but not in those with very sensitive or refractory disease. These findings, which were recently published in the journal JAMA Network Open, suggest that assessing how responsive a tumor appears to be to treatment with chemotherapy before surgery can be used to guide decisions regarding postoperative chemotherapy, thereby personalizing treatment of patients with this type of stomach cancer.